SEARCH

SEARCH BY CITATION

References

  • 1
    Eddy DM. A Manual for Assessing Health Practices and Designing Practice Guidelines: The Explicit Approach. Philadelphia: American College of Physicians, 1996.
  • 2
    American Gastroenterological Association. Policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. Gastroenterology 1995; 108: 925-926.
  • 3
    Rösch J, Keller FS. Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives. World J Surg 2001; 25: 337-346.
  • 4
    Rössle M, Richter GM, Noldge G, Palmaz JC, Wenz W, Gerok W. New non-operative treatment for variceal haemorrhage. Lancet 1989; 2: 153.
  • 5
    Rösch J, Hanafe W, Snow H, Barenfus M, Gray R. Transjugular intrahepatic portocaval shunt. Am J Surg 1971; 121: 588-592.
  • 6
    Rösch J. The creation of TIPS: a brief history. In: ConnHO, PalmazJC, RoschJ, RossleM, eds. TIPS Transjugular Intrahepatic Portosystemic Shunts. New York: Igaku-Shoin, 1996: 55-64.
  • 7
    Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. Role of transjugular intrahepatic portosystemic shunt treatment of portal hypertension and its complication: conference sponsored by the National Digestive Diseases Advisory Board. HEPATOLOGY 1995; 22: 1591-1597.
  • 8
    Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003; 124: 1700-1710.
  • 9
    Rössle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarner J-M, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171.
  • 10
    Luketic VA, Sanyal AJ. Esophageal varices. II. TIPS (transjugular intrahepatic portosystemic shunt) and surgical therapy. Gastroenterol Clin N Am 2000; 29: 387-421.
  • 11
    Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126: 858-865.
  • 12
    Sanyal AJ, Freedman AM, Luketic VA, Purdum P III, Shiffman M, Cole P, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126: 849-857.
  • 13
    Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque J, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110: 832-839.
  • 14
    Barton RE, Rosch J, Saxon RR, Lakin PC, Petersen BD, Keller FS. TIPS: short- and long-term results: a survey of 1750 patients. Semin Interv Radiol 1995; 12: 364-367.
  • 15
    Haskal ZJ, Martin L, Cardella JF, Cole P, Drooz A, Grassi CJ, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2001; 12: 131-136.
  • 16
    Haskal ZJ, Martin L, Cardella JF, Cole P, Drooz A, Grassi CJ, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003; 14: S265-S270.
  • 17
    Martin M, Zajko AB, Orons PD, Dodd G, Wright H, Colangelo J, et al. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery 1993; 114: 719-726.
  • 18
    Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992; 116: 304-309.
  • 19
    Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 1999; 19: 457-473.
  • 20
    Rossle M, Siegersterrer V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2001; 96: 3379-3383.
  • 21
    Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114: 1296-1303.
  • 22
    Sanyal A, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al., and the NASTRA group. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124: 634-631.
  • 23
    Groszmann R, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. HEPATOLOGY 2004; 39: 280-282.
  • 24
    Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004; 363: 1461-1468.
  • 25
    Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995; 23: 123-128.
  • 26
    Chalasani N, Clark WS, Martin LG, Kamean J, Khan A, Patel N, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118: 138-144.
  • 27
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC . A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. HEPATOLOGY 2000; 31: 864-871.
  • 28
    Patch D, Nikolopoulou V, McCormick A, Dick R, Amonis A, Wannamethee G, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998; 28: 454-460.
  • 29
    Ferral H, Vasan R, Speeg KV, Serna S, Young C, Postoak DW, et al. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures. J Vasc Interv Radiol 2002; 13: 1103-1108.
  • 30
    Schepke M, Roth F, Fimmers R, Brensing K-A, Sudhop T, Schild HH, et al. Comparison of MELD, Child-Pugh, and Emory Model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003; 98: 1167-1174.
    Direct Link:
  • 31
    Rajan DK, Haskal Z, Clark TW. Serum bilirubin as a predictor of early mortality after transjugular intrahepatic portosystemic shunt placement: a multivariate analysis. J Vasc Interv Radiol 2002; 13: 155-161.
  • 32
    Brensing KA, Raab P, Textor J, Gorich J, Schiedermaier P, Strunk H, et al. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt. Eur J Gastroenterol Hepatol 2002; 14: 723-731.
  • 33
    Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126: 469-475.
  • 34
    Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18: 73-89.
  • 35
    LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan R, Ascher N, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108: 1143-1151.
  • 36
    LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1993; 4: 779-786.
  • 37
    Saxon RR, Mendel-Hartvig J, Corless CL, Rabkin J, Uchida BT, Nishimine K, et al. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vasc Interv Radiol 1996; 7: 487-497.
  • 38
    Sauer P, Theilmann L, Herrmann S, Bruckner T, Roeren T, Pichter G, et al. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. HEPATOLOGY 1996; 24: 1433-1436.
  • 39
    Siegerstetter V, Huber M, Ochs A, Blum HE, Rossle M. Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment. HEPATOLOGY 1999; 29: 33-38.
  • 40
    Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron J, Pierragi M, et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. HEPATOLOGY 1997; 25: 1064-1069.
  • 41
    Sanyal AJ, Contos MJ, Yager D, Zhu YN, Willey A, Graham MF. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: characterization of cell phenotype and function. HEPATOLOGY 1998; 28: 22-32.
  • 42
    Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon SF, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. HEPATOLOGY 1997; 26: 1115-1122.
  • 43
    Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997; 113: 1623-1631.
  • 44
    Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque J, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110: 832-839.
  • 45
    Merli M, Salerno F, Riggio O, deFranchis R, Fiaccadon F, Meddi P, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). HEPATOLOGY 1998; 27: 48-53.
  • 46
    Garcia-Villarreal L, Martinez-Lagares F, Sierra A, Guevara C, Marrero J, Jimenez E, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. HEPATOLOGY 1999; 29: 27-32.
  • 47
    Sanyal AJ, Freedman AM, Luketic VA, Purdum P, Shiffman M, Tisnado J, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889-898.
  • 48
    Owens CA, Bartolone C, Warner DL, Aizenstein R, Hibblen J, Yaghmai B, et al. The inaccuracy of Duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998; 114: 975-980.
  • 49
    Haskal ZJ, Carroll JW, Jacobs JE, Arger PH, Yin D, Coleman BG, et al. Sonography of transjugular intrahepatic portosystemic shunts: detection of elevated portosystemic gradients and loss of shunt function. J Vasc Interv Radiol 1997; 84: 549-556.
  • 50
    Saxon R. A new era for transjugular intrahepatic portosystemic shunts? J Vas Interv Radiol 2004; 15: 217-219.
  • 51
    Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol 2004; 15: 239-248.
  • 52
    Haskal ZJ. Interim US multicenter results of Viatorr ePTFE TIPS endoprosthesis trial. HEPATOLOGY 2003; 38: 293A.
  • 53
    Pattynama PM, van Hoek B, Kool LJ. Inadvertent arteriovenous stenting during transjugular intrahepatic portosystemic shunt procedure and the importance of hepatic artery perfusion. Cardiovasc Interv Radiol 1995; 18: 192-195.
  • 54
    Mallery S, Freeman ML, Peine CJ, Miller RP, Stanchfield WR. Biliary-shunt fistula following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1996; 111: 1353-1357.
  • 55
    Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. HEPATOLOGY 1996; 23: 32-39.
  • 56
    Jalan R, Redhead DN, Allan PL, Hayes PC. Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 1996; 8: 381-385.
  • 57
    Conn HO. Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome. HEPATOLOGY 1996; 23: 177-181.
  • 58
    Rouillard SS, Bass NM, Roberts JP, Doherty CA, Gee L, Bacchetti P, et al. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med 1998; 128: 374-377.
  • 59
    Haskal ZJ, Pentecost MJ, Rubin RA. Hepatic arterial injuries after transjugular intrahepatic portosystemic shunt placement: report of two cases. Radiology 1993; 188: 85-88.
  • 60
    Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP 3rd, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. HEPATOLOGY 1994; 20: 46-55.
  • 61
    Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bachetti P, Roberts J, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 1995; 90: 549-555.
  • 62
    Haskal ZJ, Cope C, Soulen MC, Shlansky-Goldberg RD, Baum RA, Redd DC. Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 1995; 195: 485-488.
  • 63
    Kerlan RK Jr, LaBerge JM, Baker EL, Wack JP, Marx M, Somberg KA, et al. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1995; 6: 917-921.
  • 64
    Haskal ZJ, Middlebrook MR. Creation of a stenotic stent to reduce flow through a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1994; 5: 827-829.
  • 65
    Clavien P-A, Markus S, Tuttle-Newhall JE, Harland R, Suhocki P. Liver transplantation complicated by misplaced TIPS in the portal vein. Ann Surgery 1998; 227: 440-445.
  • 66
    Goldberg, MS, Weppler D, Khan FA, DeFaria W, Khan RT, Webb MG, et al. Does transjugular intrahepatic portosystemic shunting facilitate or complicate liver transplantation? Transplant Proc 1997; 29: 557-559.
  • 67
    Moreno A, Meneu JC, Moreno E, Fraile M, Garcia I, Loinaz C, et al. Liver transplantation and transjugular intrahepatic portosystemic shunt. Transplant Proc 2003; 35: 1869-1870.
  • 68
    Tripathi D, Therapondos G, Redhead DN, Madhavan K, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2002; 14: 827-832.
  • 69
    Boyer TD, Henderson JM. Portal hypertension and bleeding esophageal varices In: ZakimD, BoyerTD, eds. Hepatology: A Textbook of Liver Disease. 4th ed. Philadelphia: W. B. Saunders, 2002: 581-629.
  • 70
    D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. HEPATOLOGY 1995; 22: 332-353.
  • 71
    Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999; 94: 3285-3291.
    Direct Link:
  • 72
    Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatology 2003; 38: 266-272.
  • 73
    Conn HO, Lindenmuth WW May CJ, Ramsby GR. Prophylactic portacaval anastomosis. A tale of two studies. Medicine 1971; 51: 27-40
  • 74
    Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol 2003; 37: 703-704.
  • 75
    Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345: 669-681.
  • 76
    Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-659.
    Direct Link:
  • 77
    Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. HEPATOLOGY 1999; 30: 612-622.
  • 78
    Meddi P, Merli M, Lionetti R, DeSantis A, Valeriano V, Masini A, et al. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. HEPATOLOGY 1999; 29: 1074-1077.
  • 79
    Escorsell AM, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. HEPATOLOGY 2002; 35: 385-392.
  • 80
    Rosemurgy AS, Serafini FM, Zweibel BR, Black TJ, Kudryk BT, Nord HR, et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg 2000; 4: 589-597.
  • 81
    Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-987.
  • 82
    Rees CJ, Nylander DL, Thompson NP, Rose JD, Record CO, Hudson M. Do gastric and esophageal varices bleed at different portal pressures and is TIPS an effective treatment? Liver 2000; 20: 253-256.
  • 83
    Tripathi D, Therapondos G, Jackson D, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51: 270-274.
  • 84
    Barange K, Peron JM, Imani K, Otal P, Payen JL, Rousseau H, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. HEPATOLOGY 1999; 30: 1139-1143.
  • 85
    Burak KW, Lee SS, Beck PL. Portal hypertensive gastropathy and gastric vascular ectasia (GAVE) syndrome. Gut 2001; 49: 866-872.
  • 86
    Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118: 905-911.
  • 87
    Urata J, Yamashita Y, Tsuchigame T, Hatanaka Y, Matsukawa T, Sumi S, et al. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol 1998; 13: 977-979.
  • 88
    Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004: 350: 1646-1654.
  • 89
    Runyon BA. Management of adult patients with ascites due to cirrhosis. HEPATOLOGY 2004; 39: 841-856.
  • 90
    Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996; 25: 135-144.
  • 91
    Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701-1707.
  • 92
    Gines P, Uriz J, Calaborra B, Garcia-Tsao G, Kamath PS, del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839-1847.
  • 93
    Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. HEPATOLOGY 2004; 40: 629-635.
  • 94
    Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997; 17: 227-232.
  • 95
    Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89: 1520-1522.
  • 96
    Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. HEPATOLOGY 1997; 25: 1366-1369.
  • 97
    Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13: 529-534.
  • 98
    Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47: 288-295.
  • 99
    Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122: 816-822.
  • 100
    Guevara M, Gines P, Bandi JC, Gilabert R, Sort P, Jimenez W, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. HEPATOLOGY 1998; 28: 416-422.
  • 101
    Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. HEPATOLOGY 2002; 36: 941-948.
  • 102
    Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. HEPATOLOGY 2003; 38: 793-803.
  • 103
    Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. HEPATOLOGY 1998; 28: 1191-1198.
  • 104
    Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans J, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. HEPATOLOGY 2004; 39: 500-508.
  • 105
    Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. HEPATOLOGY 2002; 35: 132-139.
  • 106
    Mancuso A, Fung K, Mela M, Tibballis J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd-Chiari syndrome: a single center experience. J Hepatol 2003; 38: 751-754.
  • 107
    Rozenblit G, DelGuercio LR, Savino JA, Rundback JH, Cerabona TD, Policastro AJ, et al. Transmesenteric-transfemoral method of intrahepatic portosystemic shunt placement with minilaparotomy. J Vasc Interv Radiol 1996; 7: 499-506.
  • 108
    Matsui O, Yoshikawa J, Kadoya M, Gabata T, Takashima T, Urabe T, et al. Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach. Cardiovasc Intervent Radiol 1996; 19: 352-355.
  • 109
    DeLeve L, Shulman M, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27-41.
  • 110
    Smith FO, Johnson MS, Scherer LR, Faught P, Breitfeld PP, Albright E, et al. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease. Bone Marrow Transplant 1996; 18: 643-646.
  • 111
    Fried MW, Connaghan DB, Sharma S, Martin LG, Devine S, Holland K, et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. HEPATOLOGY 1996; 24: 588-591.
  • 112
    Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H. Transjugular intrahepatic portosystemic shunts (TIPS) for severe venoocclusive disease of the liver following bone marrow transplantation Bone Marrow Transplant 2000; 25: 987-992.
  • 113
    Zenz T, Rossle M, Bertz H, Ochs A, Finke J. Severe veno-occlusive disease after allogenic bone marrow or peripheral stem cell transplantation-role of transjugular intrahepatic portosystemic shunt (TIPS). Liver 2001; 21: 31-36.
  • 114
    Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. HEPATOLOGY 2000; 32: 859-865.
  • 115
    Paramesh AS, Husain SZ, Shneider B, Guller J, Tokat I, Gondolesi GE, et al. Improvement in hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: Case report and review of literature. Pediatr Transplantation 2003; 7: 157-162.
  • 116
    Boyer TD, Vargus EV. Transjugular intrahepatic portosystemic shunt. In: SchiffER, SorrellMF, MaddreyWC, eds. Schiff's Diseases of the Liver. 9th ed. Philadelphia: Lippincott Williams & Williams, 2003: 369-382.
  • 117
    Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18: 73-89.